The chemical substance known as 2-[4-[2-(4-Guanidinobenzamido)acetyl]-3(S)-[3-(4-guanidinobenzamido)propyl]-2-oxopiperazin-1-yl]acetic acid, with the CAS number 186971-69-7, is a complex organic compound characterized by its multi-functional structure. It features a piperazine ring, which is a common motif in pharmacologically active compounds, and incorporates guanidine groups that are often associated with biological activity, particularly in the context of enzyme inhibition or receptor modulation. The presence of acetic acid suggests potential solubility in polar solvents, while the guanidinobenzamido groups may enhance interactions with biological targets. This compound is likely to exhibit significant biological activity, making it of interest in medicinal chemistry and drug development. Its intricate structure may also imply specific stereochemical configurations that could influence its pharmacodynamics and pharmacokinetics. Overall, this substance represents a class of compounds that could be explored for therapeutic applications, particularly in areas related to cancer or metabolic disorders, although further studies would be necessary to elucidate its full potential.

2-[4-[2-(4-Guanidinobenzamido)acetyl]-3(S)-[3-(4-guanidinobenzamido)propyl]-2-oxopiperazin-1-yl]acetic acid

186971-69-7: The chemical substance known as 2-[4-[2-(4-Guanidinobenzamido)acetyl]-3(S)-[3-(4-guanidinobenzamido)propyl]-2-oxopiperazin-1-yl]acetic acid, with the CAS number 186971-69-7, is a complex organic compound characterized by its multi-functional structure. It features a piperazine ring, which is a common motif in pharmacologically active compounds, and incorporates guanidine groups that are often associated with biological activity, particularly in the context of enzyme inhibition or receptor modulation. The presence of acetic acid suggests potential solubility in polar solvents, while the guanidinobenzamido groups may enhance interactions with biological targets. This compound is likely to exhibit significant biological activity, making it of interest in medicinal chemistry and drug development. Its intricate structure may also imply specific stereochemical configurations that could influence its pharmacodynamics and pharmacokinetics. Overall, this substance represents a class of compounds that could be explored for therapeutic applications, particularly in areas related to cancer or metabolic disorders, although further studies would be necessary to elucidate its full potential.

TAK-024 is an inhibitor of platelet(IC50s of 31, 79 and 51 nM in human, monkey and guinea pig, respectively).

CAS 186971-69-7

2-[4-[2-(4-Guanidinobenzamido)acetyl]-3(S)-[3-(4-guanidinobenzamido)propyl]-2-oxopiperazin-1-yl]acetic acid

TAK-024

Ref: TM-T13065